TITLE

KUPFFER CELL DISTRIBUTION IS ALTERED ACCORDING TO THE SEVERITY OF STEATOSIS IN CHRONIC HEPATITIS C VIRUS INFECTION

AUTHOR(S)
Henderson, A.; Bigley, G.; Warnes, T.W.; McMahon, R.F.T.
PUB. DATE
April 2003
SOURCE
Gut;Apr2003 Supplement 1, Vol. 52, pA106
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The pathogenesis of hepatitis C virus (HCV) induced chronic liver disease is incompletely understood, with two main processes involved including immune mediated damage and direct cytopathic viral effects. Steatosis is thought to be a cytopathic manifestation and has been shown to be an independent risk factor for the development of fibrosis. In patients with steatosis and steatohepatitis, it has been shown that Kupffer cells are aggregated in the perivenular region. In view of the observation that 50% of patients with chronic HCV infection have steatosis, we have examined liver biopsies from 25 HCV infected individuals and control biopsies from HBV and alcohol induced liver disease for the expression of CD68, a marker oF Kupffer cells, using a standard immunohistochemiocal method. The zonal distribution of CD68 positive cells was assessed and compared with the extent of steatosis, categorised into mild, moderate and severe degrees, and with the Ishak necroinflammatory activity. In chronic HCV biopsies, there was a trend towards perivenulor distribution of CD68 positivity, particularly with increasing severity of steatosis. Biopsies showing established cirrhosis were excluded from the study and potential confounding factors of comorbidity were taken into consideration. No differences were observed related to alcohol consumption (taking 140g/week as a cut-off), obesity (BMI > 30 kg/m²) or Ishak necroinflammatory activity. The perivenular distribution of CD68 positive Kupffer cells suggests that recruitment of Kupffer cells may play a part in the pathogenesis of HCV related liver disease, through the release of TNF-α and activation of other cytokines important in the development oF inflammation and fibrosis. This zonal Iocalisation may provide insights into the mechanisms responsible For progression of chronic HCV infection, especially in those patients with significant levels of steatosis. Further work is required in this area with regard to the...
ACCESSION #
9748011

 

Related Articles

  • Effect of the interaction between steatosis and alcohol intake on liver fibrosis progression in chronic hepatitis C. Serfaty, Lawrence; Poujol-Robert, Armelle; Carbonell, Nicolas; Chazouillères, Olivier; Poupon, Renée E.; Poupon, Raoul // American Journal of Gastroenterology;Jul2002, Vol. 97 Issue 7, p1807 

    OBJECTIVES:Liver steatosis is a common histopathological finding in patients infected with hepatitis C virus. Patients with chronic hepatitis C having both steatosis and factors causing oxidative stress may be at a higher risk of fibrogenesis. In a subset of patients with a definite date of...

  • Marijuana Increases Risk of Steatosis. Kemper, Carol A. // Infectious Disease Alert;Jul2008, Vol. 27 Issue 10, p120 

    The article reports that marijuana use increases the risk of hepatic steatosis in persons with chronic hepatitis C virus (HCV) infection. It references a study by C. Hezode et al published in a 2008 issue of "Gastroenterology." Accordingly, a total of 315 HCV-infected patients were evaluated for...

  • Incidental Microvesicular Steatosis Due to Valproic Acid Anticonvulsant Therapy. Scott, David A.; Gholson, Charles F.; Netchvolodoff, Catherine V.; Ray, Monica; Gonzalez, Enrique; Bacon, Bruce R. // American Journal of Gastroenterology;Apr1991, Vol. 86 Issue 4, p500 

    Valproic acid has been implicated in at least 100 cases of fatal acute liver failure. Most cases have occurred in patients less than 10 yr old; however, at least seven have involved adults. Microvesicular steatosis has been uniformly observed, but its incidence in less severe liver disease and...

  • More Advanced Hepatic Fibrosis in Hispanics with Chronic Hepatitis C Infection: Role of Patient Demographics, Hepatic Necroinflammation, and Steatosis. Verma, Sumita; Bonacini, Maurizio; Govindarajan, Sugantha; Kanel, Gary; Lindsay, Karen L.; Redeker, Allan // American Journal of Gastroenterology;Aug2006, Vol. 101 Issue 8, p1817 

    BACKGROUND AND AIMS: We sought to assess whether Hispanics have more advanced hepatitis C virus (HCV)-related liver disease than non-Hispanic whites (NHW) and to identify contributory factors. PATIENTS AND METHODS: Patients were recruited from the Los Angeles county hepatitis clinic. Liver...

  • Hepatic steatosis: A benign disease or a silent killer. El-Zayadi, Abdel-Rahman // World Journal of Gastroenterology;7/14/2008, Vol. 14 Issue 26, p4120 

    Steatosis is a common feature of many liver diseases, namely non-alcoholic steatohepatitis (NASH) and hepatitis C virus (HCV) infection, but the pathogenic mechanisms differ. Insulin resistance (IR), a key feature of metabolic syndrome, is crucial for NASH development, associated with many...

  • Contribution of ultrasonography to the diagnosis of chronic hepatitis C histopathological changes, with emphasis on hepatic steatosis -- Part I. Matsuoka, Marcia Wang; de Oliveira, Ilka Regina Souza; Widman, Azzo; Zanoto, Arnaldo; Kodaira, Sérgio Keidi; Marinho, Leonardo Ellery; Filho, Wilson Jacob; Cerri, Giovanni Guido // Radiologia Brasileira;may/jun2011, Vol. 44 Issue 3, p141 

    Objective: To evaluate the role of ultrasonography in the assessment of histopathological changes in patients with chronic hepatitis C, with emphasis on hepatic steatosis. Materials and Methods: Liver ultrasonography results were compared with histopathological findings of liver biopsy of 192...

  • Recreational Drugs: a New Health Hazard for Patients with Concomitant Chronic Liver Diseases. Tarantino, Giovanni; Citro, Vincenzo; Finelli, Carmine // Journal of Gastrointestinal & Liver Diseases;Mar2014, Vol. 23 Issue 1, p79 

    Our purpose in this article is to review the effects of recreational drugs, used either on their own but principally combined with alcohol consumption, in determining hepatic injury or influencing the evolution of some chronic diseases of the liver, specifically HCV infection and NAFLD. A...

  • Serum leptin levels correlate with hepatic steatosis in chronic hepatitis C. Romero-Gómez, Manuel; Castellano-Megias, Victor M.; Grande, Lourdes; Irles, José A.; Cruz, Marina; Nogales, Marí Carmen; Alcón, Juan Carlos; Robles, Antonio // American Journal of Gastroenterology;May2003, Vol. 98 Issue 5, p1135 

    : ObjectivesHepatic steatosis (HS) has been related to obesity and fibrosis in chronic hepatitis C (CHC). The aim of this study was to determine the role of leptin system in HS development.: MethodsPatients (n = 131) with biopsy-proven CHC, positive HCV RNA, and raised ALT were enrolled. Body...

  • Steatosis in chronic hepatitis C: fuel for overproduction of oxidative stress? Koike, Kazuhiko // Journal of Gastroenterology;Jun2005, Vol. 40 Issue 6, p664 

    In this article, the author discusses in situ detection of oxidized n-3 polyunsaturated fatty acids in chronic hepatitis C in correlation with hepatic steatosis. Endogenous oxidative stress generated by multiple intracellular pathways is an important class of naturally occurring carcinogens....

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics